[
  {
    "ticker": "IFT",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02965837",
    "id": "02965837",
    "pages": 3,
    "price_sensitive": false,
    "date": "20250704",
    "time": "0803",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250704/pdf/06lg3p5jbd4xh3.pdf",
    "summary": "<h3><strong>Infratil Limited - CDC Independent Valuation (30 June 2025) - Material Information Summary</strong></h3>\n<ul>\n<li><strong>Valuation Increase</strong>: Infratil\u2019s 49.76% stake in CDC increased by <strong>A$148M</strong> (midpoint: <strong>A$6.75B</strong> vs. A$6.60B in March 2025).  </li>\n<li><strong>Equity Valuation Decline</strong>: CDC\u2019s 100% equity value decreased <strong>1%</strong> to <strong>A$13.56B</strong> (from A$13.70B), driven by higher assumed interest costs.  </li>\n<li><strong>Capital Deployment</strong>: Infratil acquired an additional <strong>1.58% stake for A$220M</strong>, increasing ownership to <strong>49.76%</strong>. Further <strong>A$250M</strong> commitment expected within 12 months.  </li>\n<li><strong>Operational Update</strong>:  </li>\n<li><strong>Added 54MW operational capacity</strong> (Auckland), total operational capacity now <strong>372MW</strong>.  </li>\n<li><strong>Under construction</strong>: <strong>453MW</strong> (up from 382MW), including expansions in Melbourne (+105MW) and Canberra (+19MW).  </li>\n<li><strong>Valuation Methodology Shift</strong>: Primary method changed to <strong>DCF</strong> (from Historical Transaction), with unchanged <strong>cost of equity (11.05%)</strong> and <strong>terminal growth (2.5%)</strong>.  </li>\n</ul>\n<p><em>Omitted: Regional breakdowns, minor assumption adjustments, and non-material pipeline details.</em></p>",
    "usage": {
      "prompt_tokens": 1538,
      "completion_tokens": 296,
      "total_tokens": 1834,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-03T22:14:57.776859"
  },
  {
    "ticker": "CEN",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02965835",
    "id": "02965835",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250704",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250704/pdf/06lg3b1ykjjrgf.pdf",
    "summary": "<h3>Summary of Material Information:</h3>\n<ul>\n<li><strong>Gas Supply Agreement</strong>: Contact Energy signs 7-year deal with GGNZ Ltd for <strong>up to 7PJ/year</strong> of gas supply (effective <strong>1 October 2025</strong>), with a <strong>3-year extension option</strong> from 2032.  </li>\n<li><strong>Strategic Impact</strong>: Diversifies gas supply, reduces reliance on single field, supports retail gas customers and peaking generation.  </li>\n<li><strong>Renewable Transition</strong>: Expected <strong>200\u2013300GWh/year</strong> of gas-fired generation (peaking units), supporting <strong>98% renewable output</strong> (post-Taranaki CC closure in late 2025).  </li>\n<li><strong>Investment Context</strong>: Part of <strong>&gt;$2B committed</strong> in renewable projects over past 4 years; net zero generation target by 2035.  </li>\n</ul>\n<p><em>No direct trading/capital markets action required.</em></p>",
    "usage": {
      "prompt_tokens": 736,
      "completion_tokens": 177,
      "total_tokens": 913,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-03T22:14:43.314368"
  },
  {
    "ticker": "AFP",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02965836",
    "id": "02965836",
    "pages": 2,
    "price_sensitive": false,
    "date": "20250704",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250704/pdf/06lg3d4pnlp9vn.pdf",
    "summary": "<ul>\n<li><strong>Director Share Purchase</strong>: Hartley Campbell Atkinson (Director of AFT Pharmaceuticals) acquired 200,000 ordinary shares at an average price of NZD $2.83 per share (~NZD $566,000 total).  </li>\n<li><strong>Post-Transaction Holdings</strong>: Total holding via the Atkinson Family Trust increased to <strong>72,259,496 shares</strong> (from 72,059,496). Direct beneficial ownership: <strong>867,826 shares</strong>.  </li>\n<li><strong>Transaction Dates</strong>: On-market purchases executed on <strong>30 Jun, 1 Jul, and 2 Jul 2025</strong>.  </li>\n</ul>\n<p><em>No material impact on capital structure or liquidity identified. Disclosure reflects routine director trading.</em></p>",
    "usage": {
      "prompt_tokens": 1408,
      "completion_tokens": 136,
      "total_tokens": 1544,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-03T22:15:17.197946"
  },
  {
    "ticker": "AIZ",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02965834",
    "id": "02965834",
    "pages": 8,
    "price_sensitive": false,
    "date": "20250704",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250704/pdf/06lg37zrjmg86g.pdf",
    "summary": "<h3><strong>Material Information Summary \u2013 Air New Zealand (ASX) \u2013 Monthly Traffic &amp; Media Updates</strong></h3>\n<h4><strong>Key Operational Metrics (May 2025 vs. Prior Year)</strong></h4>\n<ul>\n<li><strong>Capacity Reduction</strong>: Group ASKs down <strong>2.7%</strong> (Long Haul: <strong>-2.2%</strong>, Domestic: <strong>-5.5%</strong>, Short Haul Int\u2019l: <strong>-2.2%</strong>) due to engine maintenance delays.  </li>\n<li><strong>Load Factor Improvement</strong>: Group PLF up <strong>2.5 pts</strong> to <strong>82.0%</strong> (YTD: <strong>+1.9 pts</strong> to <strong>83.5%</strong>).  </li>\n<li><strong>Revenue Strength</strong>: YTD underlying RASK up <strong>2.0%</strong> (Long Haul: <strong>+2.8%</strong>, Short Haul: <strong>+0.4%</strong>).  </li>\n<li><strong>Asia Outperforms</strong>: Passenger growth to Asia up <strong>5.0%</strong> (May), <strong>8.0%</strong> YTD; RASK up <strong>4.8 pts</strong> for May.  </li>\n</ul>\n<h4><strong>Media Releases (Material Impact Highlights)</strong></h4>\n<ol>\n<li><strong>Tasman/Pacific Expansion</strong>: <strong>1.7M seats</strong> added (Oct 2025\u2013Mar 2026), with <strong>130K extra seats</strong> (+8% premium) and 42 weekly widebody flights.  </li>\n<li><strong>China Tourism Partnership</strong>: Joint <strong>$500K NZD</strong> marketing push with Air China to boost inbound travel; <strong>33% premium seat increase</strong> on Shanghai\u2013Auckland route.  </li>\n<li><strong>North America Capacity</strong>: <strong>34K additional seats</strong> (Oct\u2013Mar), including <strong>20.5K premium seats</strong> (+15% YoY); 787 retrofits for enhanced cabins.  </li>\n<li><strong>New Routes/Domestic Boost</strong>:  </li>\n<li><strong>Christchurch\u2013Adelaide</strong> (seasonal, 15K seats from Oct 2025).  </li>\n<li><strong>36K extra domestic seats</strong> (Auckland\u2013South Island routes, winter 2025).  </li>\n<li><strong>Fleet Expansion</strong>: Two new <strong>A321neos</strong> (214 seats each) to add <strong>70K annual seats</strong>; first entered service June 2025.  </li>\n</ol>\n<h4><strong>No Material Information Identified</strong>:</h4>\n<ul>\n<li>Capital structure changes, dividends, or liquidity updates.  </li>\n</ul>\n<p><strong>Brevity Note</strong>: Excluded routine director quotes, FX impacts, and non-material regional stats. Focused on capacity, revenue drivers, and network changes impacting demand/costs.  </p>\n<hr />\n<p><em>Summary tailored for trading/capital decisions: Prioritizes operational trends, revenue metrics, and growth initiatives.</em></p>",
    "usage": {
      "prompt_tokens": 5323,
      "completion_tokens": 544,
      "total_tokens": 5867,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-03T22:15:09.005850"
  },
  {
    "ticker": "THL",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02965833",
    "id": "02965833",
    "pages": 2,
    "price_sensitive": true,
    "date": "20250704",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250704/pdf/06lg35x0wyqz8c.pdf",
    "summary": "<p><strong>THL Updated FY25 Guidance Summary:</strong>  </p>\n<ul>\n<li><strong>FY25 uNPAT guidance:</strong> Expected at lower end of analyst range ($27.0M\u2013$34.4M), weighed by weak global RV sales and softer USA market.  </li>\n<li><strong>Manufacturing divisions (AU/NZ):</strong> Earnings decline due to reduced production volumes and inventory adjustments.  </li>\n<li><strong>FY26 outlook:</strong>  </li>\n<li>Net debt: ~$500M (ex-IFRS 16 leases).  </li>\n<li>Forward rental revenue growth: Double-digit % in AU/NZ (25% ahead of prior year); USA bookings recovering post-Liberation Day decline (single-digit % drop YoY).  </li>\n<li><strong>Potential impairments:</strong> Goodwill (NZ$36M, USA business) under review; other non-cash items may impact statutory NPAT (no covenant impact).  </li>\n</ul>\n<p><em>Materially negative:</em> Earnings pressure, potential impairment, and cyclical challenges highlighted.</p>",
    "usage": {
      "prompt_tokens": 1274,
      "completion_tokens": 191,
      "total_tokens": 1465,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-03T22:15:25.778645"
  }
]